Diabetes drug ‘increases bladder cancer risk by 63%’, study suggests

31 Mar 2016


Pioglitazone, a drug used to treat people with diabetes, could increase bladder cancer risk, suggests new research in the BMJ.

Huffington Post


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story